Stromal Vascular Fraction Enriched PRP in Treatment of Post-acne Scars
ConditionAcne Scars - Atrophic
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-40
SponsorZagazig University
About this trial
in a split face fashion, 30 patients will be randomized into 3 groups: Group A: rt side treated with SVF enriched PRP, lt side treated with prp Group B: rt side treated with SVF enriched PRP, lt side treated with SVF Group C: rt side treated with PRP, lt side treated with SVF
Eligibility criteria
This trial accepts healthy volunteersQualifiers
patients with atrophic post acne scars without any previous treatment trials.
adequate blood picture, no anemia, no bleeding or platelet disorders.
Disqualifiers
pregnant and lactating females.
elderly.
patients with bleeding tendencies.
Trial design
Design model
Parallel
Treatments tested in this trial
Stromal vascular fraction (SVF) enriched platelet rich plasma (PRP) versus each alone
Biological/VaccineAdipose derived stromal vascular fraction cells will be aspirated and isolated from patient autologous adipose tissue and used to enrich patient's autologous platelet rich plasma then will be used to treat atrophic post acne scars versus each alone.
Treatment groups
30 Participants
are divided into 3 treatment groupsGroup A: SVF enriched PRP vs PRPExperimental treatment 1 intervention
Group B: SVF enriched PRP vs SVFActive comparator 1 intervention
Group C: PRP vs SVFActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
change in severity of acne scars using Goodman scoring system
at baseline, acne scars will be assessed clinically using the 4 point grading system proposed by Goodman \&colleagues in 2006, patients' complaints and expectations will be addressed as well and the impact of acne scars on patients' quality of life will be investigated using the dermatology life quality index (DLQI). Goodman scoring system will be used at the last session and at the follow up visit to measure the change pre and post treatment.
Time frame
3 monthly sessions and follow up for 3 months after the last visitSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: